Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ads free!Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ads free today!Spring sale! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Johnson and Johnson
Pharmaceuticals
Nike
Verizon
Moderna
ExxonMobil
General Motors
Apple
Nordstrom
Expedia
Kroger
Walmart
AMC
Ford Motor
Alphabet
GameStop
Amazon
Costco
Topics

Advertisement

Johnson and Johnson

Share

Top Latest Popular

In the last 8 hours

Johnson & Johnson Stock a Strong Buy in 2026 for Dividend Growth and Healthcare Stability International Business Times - AU Edition 16:15

Johnson & Johnson launches ‘Generation Fine’ depression project FiercePharma 14:48

Earlier Today

3 Unstoppable Dividend King Stocks to Buy Right Now for Less Than $550 The Motley Fool 13:15

Advertisement

Advertisement

J&J seeks to rewrite the script on depression treatment pharmaphorum 11:51

Meta, Amazon and J&J power Perigus Energy’s European CPPA portfolio PV Magazine 08:08

J&J Feared FDA's 'Disturbing Proposal' To Test Talc, Jury Told Law360 02:33

Yesterday

DDW: Combination Therapy Shows Efficacy for Crohn Disease, Ulcerative Colitis Endocrinology Advisor 14:53 Thu, 07 May

Johnson & Johnson launches "Generation Fine," a New Movement Encouraging Patients to Expect More from Depression Treatment and Aim for Remission PR Newswire (Press Release) 13:01 Thu, 07 May

Campaign highlights low expectations among patients with depression Pharmafile 11:19 Thu, 07 May

Johnson And Johnson Gains STELARA Approval As Shares Trade Below Targets Simply Wall St 11:02 Thu, 07 May

J&J, Tolmar Settle Patent Case Over Antipsychotic Drug Law360 03:28 Thu, 07 May

'Do Not Use This Report': J&J Hid Asbestos Test, Jury Told Law360 03:08 Thu, 07 May

Wednesday

Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson? The Motley Fool 21:11 Wed, 06 May

Combination Therapy Shows Efficacy for Crohn Disease, Ulcerative Colitis Clinical Pain Advisor 20:35 Wed, 06 May

Is Johnson & Johnson Still the Ultimate Safe Dividend Stock to Buy? The Motley Fool 19:09 Wed, 06 May

Critical Mass With Law.com's Amanda Bronstad: 2nd Bellwether Trial Opens in LA Over J&J Talc, Federal Judge Calls $7.25B Roundup Settlement ‘Mind-Boggling' Law.com 16:10 Wed, 06 May

Modicus Prime Raises $8M to Enable AI Audit Readiness Across Pharma PR Newswire (Press Release) 14:04 Wed, 06 May

Advertisement

J&J’s soft tissue surgical robot succeeds in pivotal gastric bypass study Clinical Trials Arena 09:50 Wed, 06 May

Ex-FDA Chief Testifies 100s Of J&J Docs Tie Asbestos To Talc Law360 04:13 Wed, 06 May

‘Where Is the Actual Evidence of Asbestos?': Johnson & Johnson Returns to Calif. Court in 2nd Bellwether Talc Trial Law.com 01:15 Wed, 06 May

Tuesday

J&J Moves JNJ-4804 Into Phase III Despite Mixed Efficacy Results Scrip Pharma Intelligence 21:16 Tue, 05 May

STAT Plus: Pharmalittle: We’re reading about RFK Jr. targeting antidepressants, J&J pushing an IBD drug, and more STAT 14:15 Tue, 05 May

Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease PR Newswire (Press Release) 13:07 Tue, 05 May

Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn's disease PR Newswire (Press Release) 13:07 Tue, 05 May

Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System Business Wire (Press Release) 12:01 Tue, 05 May

Study highlights breakthrough in overcoming diminishing returns of sequential IBD therapies News-Medical.Net 10:44 Tue, 05 May

STAT Plus: Johnson & Johnson advances IBD therapy, despite trial miss STAT 06:10 Tue, 05 May

Delaware Courts Sharpen Focus on Earn Outs: Review of Recent Case Law and Practical Guidance for Dealmakers JD Supra 05:18 Tue, 05 May

'They Knew It': J&J Accused Of Hiding Talc Risk At LA Trial Law360 03:17 Tue, 05 May

Monday

Delaware Supreme Court Upholds Extracontractual Fraud Claim in Earnout Dispute JD Supra 18:54 Mon, 04 May

Are Wall Street Analysts Bullish on Johnson & Johnson Stock? Barchart 15:40 Mon, 04 May

The Best Dividend Stocks to Buy and Hold Forever The Motley Fool 09:59 Mon, 04 May

In the last month

On the Move: Koors to Head J&J Investor Relations O'Dwyer's PR Daily 21:42 Fri, 01 May

Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio Zacks 17:51 Fri, 01 May

Medcura Appoints Medical Device Industry Veteran Gary P. Fischetti to Board of Directors PR Newswire (Press Release) 15:01 Fri, 01 May

M&A Earnouts, Risk Allocation, and Post-Closing Incentive Conflicts CLS Blue Sky 06:05 Fri, 01 May

J&J Says Ill. Ruling Backs Beasley Allen's DQ From Talc Suits Law360 20:47 Thu, 30 Apr

Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations Business Wire (Press Release) 13:09 Thu, 30 Apr

People left with cancer linked to Johnson & Johnson talcum powder 'dying every three days', High Court hears MailOnline 12:08 Thu, 30 Apr

Johnson & Johnson Milestones Reframe Growth And Valuation Picture For Investors Simply Wall St 11:05 Thu, 30 Apr

Advertisement

Advertisement

About our Johnson & Johnson news

Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis